Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore ...

Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

In a step forward for Australian dementia research, a new collaborative research project has been announced. America-based ...

However, considering it hovered near bear market territory a few weeks ago, things aren't so bad. Stocks might not be out of ...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

The event, called All-Star Cure, will take place July 12-13 at the IU Simon Comprehensive Cancer Center, before the WNBA ...